Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT201 vs Botox for glabellar frown lines in Chinese subjects
CTR20171186Phase 3Completed
- Sponsor
- Merz
- Start
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in glabellar furrowing, sponsored by Merz. Started Oct 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on CTR20171186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171186.